Study of Congenital Myasthenic Syndrome (CMS) Over Time
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study follows people with congenital myasthenic syndrome (CMS) over time to learn more about how the condition changes and to find better ways to measure symptoms. You will not receive any treatment, but your participation helps researchers understand CMS better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed genetic diagnosis of congenital myasthenic syndrome (CMS).
- You can be any age, including children 6 months and older.
- You need to be in stable health, not having a major flare-up or other serious illness.
- You cannot have had gene therapy before joining the study.
- If you are pregnant, you cannot take part at this time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This natural history study follows children and adults with suspected or confirmed mitochondrial myopathy to better understand symptoms and how the condition changes. It may also include healthy participants to compare test results and improve future treatments.
This study is a long-term follow-up for people with myotonic dystrophy type 1. It aims to find better ways to measure how the disease progresses, which could help develop future treatments.
This study follows people with congenital myasthenic syndrome (CMS) caused by changes in certain genes (DOK7, MUSK, AGRN, or LRP4) over time. It does not test any new drug, but helps researchers understand how the condition changes and how to plan future treatments.
This trial tests a new medicine, adimanebart, for people with certain types of congenital myasthenic syndrome (CMS), a condition that causes muscle weakness. The study aims to see if the medicine improves muscle strength and daily function, and it includes both teenagers and adults.
This study looks at how to best measure muscle health and function in children with myotonic dystrophy. It may help prepare for future treatment trials.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
Hear when a new Myasthenic Syndromes, Congenital trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.